Recur

Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million

In recent years, health professionals and the general public alike have been acutely aware of the potential ravages that could result from a flu pandemic. Although many people might still recall the pandemics of 1968 and 1957, it is the infamous 1918-1920 pandemic--and the possibility of a recurrence on that scale--that causes the most trepidation. Strangely, researchers still don't kno...

Pourquié lab identifies genes involved in formation of vertebral precursors

Mary Lee Dequeant, Ph.D., a Predoctoral Researcher at the Stowers Institute for Medical Research, and Olivier Pourquié, Ph.D., Stowers Institute Investigator and an investigator with the Howard Hughes Medical Institute, are the first and last authors, respectively, on a paper that identifies a network of cyclic genes that shed light on the molecular basis of spine formation in the embryo. <...

Transplanted photoreceptor precursor cells restore visual function in mice with retinal degeneration

Scientists have successfully transplanted light-sensing cells called photoreceptors directly into the eyes of mice and restored their visual function. The achievement is based on a novel technology in which the cells are introduced at a particular stage in their development. It was carried out at the London Institute of Ophthalmology using a novel approach developed at the University of...

Adding radiation decreases breast cancer recurrence

Radiotherapy after breast conserving surgery for breast cancer reduces recurrence and prevents development of additional breast tumors in older women with early stage breast disease, according to a new study. Published in the March 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that women also benefit from the recommended five years of tamoxife...

Recur at Biology Products

Rabbit Anti-Human Amyloid Precursor Protein (KP1 Domain) Polyclonal Antibody, Unconjugated from AbD Serotec

Description:RABBIT ANTI HUMAN APP (KP1 DOMAIN) Immunogen: Synthetic peptide composed of amino acids 292-312 from the KPI domain of human APP....
Company:AbD Serotec

Recur at Biology Technology

Precursor miRNAs for Successful miRNA Functional Studies

miRNA target site identification and validation Screening for miRNAs that regulate target gene expression Screening for miRNAs that affect a cellular process MicroRNAs (miRNAs) are small, regulatory...

Recur at Medicine News

Radiation before surgery cuts cancer recurrence

According to a report, giving radiation to surgical treatment for rectal cancer may not make much difference in the survival of patients. But the findings suggest that the radiation treatments given before surgery may help improve the patient's quality of life by reducing the rate of cancer recurrence at or near the original tumor site in the rectum. In about 15% to 45% of patients who...

Heparin does not protect from recurrent heart attacks

Professor Mahaffey and his team from Duke Clinical Research Institute have found that either form of heparin (both low molecular weight and unfractionated)gives emergency// protection to heart attack patients by breaking the clots in blood flow to the heart reducing the risk of heart attacks for 24 hours. Though both the forms of heparin gives emergency treatment they are not found to avo...

Estrogen Does Not Prevent Recurrent Strokes

Despite some past evidence that hormone replacement might lower stroke risk in older women, new research shows that estrogen therapy does not protect women from recurrent strokes and may instead carry some risks. The findings add to growing evidence that hormone replacement therapy does not have the cardiovascular benefits doctors once believed. // Many doctors have long thought hormo...

Radiation reduces cancer recurrence

According to a report, giving radiation to surgical treatment for rectal cancer may not make much difference in the survival of patients. But the findings suggest that the radiation treatments given before surgery //may help improve the patient's quality of life by reducing the rate of cancer recurrence at or near the original tumor site in the rectum. In about 15% to 45% of patients w...

Lowering Risk of Breast Cancer Recurrence

A new class of drugs could reduce the risk of breast cancer recurrence in post-menopausal women.Exemestane is a third-generation aromatase inhibitor. Aromatase inhibitors are drugs that block the conversion of precursor molecules. In the case of breast cancer, aromatase inhibitors block the conversion of precursor molecules into various types of estrogenic compounds. //In a new study, coo...

More>>

Recur at Medicine Products

No data found

Search Recur medicine products at Google

Search Recur medicine products at Yahoo

Search Recur medicine products at Msn

Recur at Medicine Technology

New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants

Prophylaxis with Synagis Decreases Incidence of Recurrent Wheeze byAlmost Half ABBOTT PARK, Ill. and GAITHERSBURG, Md., June 29, 2007/PRNewswire-FirstCall/ -- Abbott and MedImmune today announcedresults of a new study, published in the July issue of Journal ofPediatrics, showing that treatment with Synagis(R) (palivizumab)may reduce recurrent wheezing in premature infants by almosthalf.<...

Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer

WAILEA, Hawaii and SUNNYVALE, Calif., June 27, 2007/PRNewswire-FirstCall/ -- Pharmacyclics, Inc. today announcedpreliminary results from two open-label, multi-center Phase 2clinical trials supporting the potential use of Xcytrin(R)(motexafin gadolinium) Injection, the company's lead productcandidate, in combination with Alimta(R) (pemetrexed) and incombination with Taxotere(R) (docetaxel...

Antisense Pharma: Promising Phase IIb Results of Targeted Therapy with AP 12009 in Recurrent Anaplastic Astrocytoma

CHICAGO and REGENSBURG - June 21, 2007 - “In anaplasticastrocytoma, AP 12009 as a monotherapy is actually clearly superiorto temozolomide,” Prof. Albert Wong, M.D., StanfordUniversity, California, U.S.A. commented on the international PhaseIIb study with the TGF-beta 2-inhibitor AP 12009, under developmentby Antisense Pharma. Prof. Wong discussed the results of the studyin th...

Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)

Phase II GBM study presented at ASCO with cediranib - a selectiveVEGF signaling inhibitor - shows over a quarter of patients aliveand progression- free at six months(1) CHICAGO, June 04, 2007 /PRNewswire/ -- Data for theinvestigational agent cediranib (AZD2171) were presented today atthe annual meeting of the American Society of Clinical Oncology(ASCO) from a study in patients with recurr...

Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer

- Data Support Rationale for Comprehensive Ongoing Phase 2 Programas Combination Agent with Standard Chemotherapies and Pivotal LungCancer Trial Scheduled to Begin Early Next Year - CHICAGO and SUNNYVALE, Calif. June 01, 2007/PRNewswire-FirstCall/ -- Pharmacyclics, Inc. today announcedpromising preliminary results from an open-label Phase 2 clinicaltrial of Xcytrin(R) (motexafin gadoliniu...

More>>